文献速递姑息放疗与转移瘤消化道肿瘤放疗放疗物理与技术

结直肠癌脊柱骨转移:姑息放疗后稳定性、预后因素与生存的回顾性分析

Spinal bone metastases in colorectal cancer: a retrospective analysis of stability, prognostic factors and survival after palliative radiotherapy.
PubMed 文献 · Radiat Oncol · 2017-07-11

结果显示放疗后新发骨折或进展仅4%,不稳定病灶再钙化率低(3%和9%),中位骨生存4.2个月,KPS<70%、化疗和双膦酸盐治疗为骨生存预后因素。

要点

  • 放疗后新发骨折或椎体进展仅4%,但不稳定病灶再钙化率低(3%和9%)。
  • 中位骨生存4.2个月,放疗后6个月61%患者死亡。
  • KPS<70%、化疗和双膦酸盐治疗是骨生存的预测预后因素。

核心结论

  • 结直肠癌脊柱骨转移患者骨生存差,放疗后3和6个月不稳定病灶再钙化率低。
  • 为避免不必要的住院并改善剩余生活质量,尤其KPS<70%患者,可优先选择短程分割放疗。

研究设计与样本

  • 放疗前及放疗后3、6个月基于治疗计划CT和随访CT按Taneichi骨稳定性评分评估每个受累椎体。
  • 评估骨生存率(放疗首日至任何原因死亡时间)及骨生存预后因素。

主要发现

  • 放疗前59例(63%)按Taneichi评分评为不稳定。
  • 放疗前43例(46%)在照射区域内诊断病理性骨折。
  • 放疗后4例(4%)诊断新骨折或既往塌陷椎体进展。
  • 不稳定骨转移灶显著再钙化和稳定仅见于3/59例(3%)和5/59例(9%)。
  • 中位骨生存4.2个月(范围0.5-67.3个月),放疗后6个月61%患者死亡。

关键数值与推荐

  • KPS(<70% vs ≥70%)、化疗和双膦酸盐治疗是骨生存的预测预后因素。

临床怎么用

  • 对结直肠癌脊柱骨转移姑息放疗患者,尤其KPS<70%者,可优先选择短程分割放疗以避免不必要住院并改善剩余生活质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This retrospective analysis aimed to analyse the stability of spinal bone metastases in colorectal cancer (CRC) patients following radiotherapy (RT) by use of a validated score and to assess prognostic factors for stability and survival. METHODS: Ninety-four patients with osteolytic spinal bone metastases from CRC were treated at the Department of Radiation Oncology at the University Hospital Heidelberg between 2000 and 2014. The stability of each affected vertebral body was assessed according to the validated Taneichi bone stability score on the basis of the treatment planning CT scan prior to RT and also based on the follow-up CT examinations at 3 and 6 months after RT. Additionally, bone survival rates (time between first day of RT and death from any cause) as well as prognostic factors for bone survival were evaluated for all study patients. RESULTS: Before RT, 59 patients (63%) were rated unstable according to the Taneichi score. Pathological fractures within the irradiated region were diagnosed in 43 patients (46%) prior to RT. New fractures or progression of previously collapsed vertebrae were diagnosed in 4 patients (4%) after irradiation. Significant re-calcification and stabilization of former unstable bone metastases was only observed in 3/59 patients (3%) and 5/59 patients (9%). The median bone survival was 4.2 months (range 0.5-67.3 months) and 6 months after RT 61% of the patients were dead. Karnofsky performance score (KPS) (< 70% vs. ≥ 70%), chemotherapy and bisphosphonate therapy were predictive prognostic factors for bone survival. CONCLUSIONS: Our study population is characterized by poor bone survival and low re-calcification rates of unstable spinal bone lesions 3 and 6 months after RT. To avoid unnecessary hospitalisation and improve remaining QoL, short fractionated treatment schedules of RT may be prefered in this highly palliative situation, particularly for patients with a KPS < 70%.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Bostel T, Förster R, Schlampp I, et al. Spinal bone metastases in colorectal cancer: a retrospective analysis of stability, prognostic factors and survival after palliative radiotherapy. Radiat Oncol. 2017. PMID: 28697786. doi:10.1186/s13014-017-0852-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。